fluphenazine has been researched along with amphotericin b in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Rahkhoodaee, F; Raymond, M; Tsao, S | 1 |
| Berellini, G; Lombardo, F; Springer, C; Waters, NJ | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Morenz, E; Morenz, J; Schmidt, D | 1 |
| Dai, HQ; Huang, P; Pei, G; Ren, B; Su, MY; Tong, YJ; Yang, N; Yang, YZ; Zhang, LX; Zhuo, Y | 1 |
| Guo, Q; Hu, T; Lu, Y; Mo, L; Peng, X; Ren, B; Xu, X; Zhou, X; Zhou, Z | 1 |
1 review(s) available for fluphenazine and amphotericin b
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for fluphenazine and amphotericin b
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Rhodamines | 2009 |
In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set.
Topics: Computational Biology; Humans; Least-Squares Analysis; Linear Models; Nonlinear Dynamics; Pharmacokinetics; Principal Component Analysis | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Effect of drugs on superoxide formation by neutrophilic granulocytes].
Topics: Amphotericin B; Chloramphenicol; Colchicine; Fluphenazine; Humans; Hydrocortisone; Levamisole; Lithium; Lithium Carbonate; Neutrophils; Ouabain; Propranolol; Superoxides | 1987 |
ABC transporters coupled with the elevated ergosterol contents contribute to the azole resistance and amphotericin B susceptibility.
Topics: Amphotericin B; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albicans; Drug Resistance, Fungal; Drug Synergism; Ergosterol; Fluphenazine | 2014 |
Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis.
Topics: Amphotericin B; Animal Structures; Animals; Antifungal Agents; Antipsychotic Agents; Candida albicans; Candidiasis; Colony Count, Microbial; Disease Models, Animal; Drug Interactions; Fluconazole; Fluphenazine; Gene Expression Profiling; Gene Expression Regulation, Fungal; Mice; Treatment Outcome | 2019 |